CLDN1 and hepatocellular carcinoma: Since TACSTD2 was reported to interact with the HCV-entry cofactor CLDN1 in human corneal epithelial cells [21], we examined the interaction between TACSTD2 and CLDN1 in hepatoma cells by co-immunoprecipitation.